Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 300

1.

Determination of the pathogenicity of known COL4A5 intronic variants by in vitro splicing assay.

Horinouchi T, Nozu K, Yamamura T, Minamikawa S, Nagano C, Sakakibara N, Nakanishi K, Shima Y, Morisada N, Ishiko S, Aoto Y, Nagase H, Takeda H, Rossanti R, Kaito H, Matsuo M, Iijima K.

Sci Rep. 2019 Sep 3;9(1):12696. doi: 10.1038/s41598-019-48990-9.

2.

Pyrimidotriazine derivatives as selective inhibitors of HBV capsid assembly.

Toyama M, Sakakibara N, Takeda M, Okamoto M, Watashi K, Wakita T, Sugiyama M, Mizokami M, Ikeda M, Baba M.

Virus Res. 2019 Oct 2;271:197677. doi: 10.1016/j.virusres.2019.197677. Epub 2019 Jul 31.

PMID:
31376401
3.

Comparison between conventional and comprehensive sequencing approaches for genetic diagnosis of Alport syndrome.

Yamamura T, Nozu K, Minamikawa S, Horinouchi T, Sakakibara N, Nagano C, Aoto Y, Ishiko S, Nakanishi K, Shima Y, Nagase H, Rossanti R, Ye MJ, Nozu Y, Ishimori S, Morisada N, Kaito H, Iijima K.

Mol Genet Genomic Med. 2019 Sep;7(9):e883. doi: 10.1002/mgg3.883. Epub 2019 Jul 30.

4.

Molecular Mechanisms of p63-Mediated Squamous Cancer Pathogenesis.

Moses MA, George AL, Sakakibara N, Mahmood K, Ponnamperuma RM, King KE, Weinberg WC.

Int J Mol Sci. 2019 Jul 23;20(14). pii: E3590. doi: 10.3390/ijms20143590. Review.

5.

Intersection of the p63 and NF-κB pathways in epithelial homeostasis and disease.

King KE, George AL, Sakakibara N, Mahmood K, Moses MA, Weinberg WC.

Mol Carcinog. 2019 Sep;58(9):1571-1580. doi: 10.1002/mc.23081. Epub 2019 Jul 8. Review.

PMID:
31286584
6.

Clinical characteristics of HNF1B-related disorders in a Japanese population.

Nagano C, Morisada N, Nozu K, Kamei K, Tanaka R, Kanda S, Shiona S, Araki Y, Ohara S, Matsumura C, Kasahara K, Mori Y, Seo A, Miura K, Washiyama M, Sugimoto K, Harada R, Tazoe S, Kourakata H, Enseki M, Aotani D, Yamada T, Sakakibara N, Yamamura T, Minamikawa S, Ishikura K, Ito S, Hattori M, Iijima K.

Clin Exp Nephrol. 2019 Sep;23(9):1119-1129. doi: 10.1007/s10157-019-01747-0. Epub 2019 May 27.

PMID:
31131422
7.

Molecular assay for an intronic variant in NUP93 that causes steroid resistant nephrotic syndrome.

Rossanti R, Shono A, Miura K, Hattori M, Yamamura T, Nakanishi K, Minamikawa S, Fujimura J, Horinouchi T, Nagano C, Sakakibara N, Kaito H, Nagase H, Morisada N, Asanuma K, Matsuo M, Nozu K, Iijima K.

J Hum Genet. 2019 Jul;64(7):673-679. doi: 10.1038/s10038-019-0606-4. Epub 2019 Apr 23.

PMID:
31015583
8.

Correction to "Plasma-Ice Interface as Thermodynamically Size-Tunable Reaction Field: Development of Plasma-Assisted Freeze Templating".

Sakakibara N, Ito T, Terashima K.

Langmuir. 2019 Mar 12;35(10):3869. doi: 10.1021/acs.langmuir.9b00465. Epub 2019 Mar 1. No abstract available.

PMID:
30821978
9.

Plasma-Ice Interface as Thermodynamically Size-Tunable Reaction Field: Development of Plasma-Assisted Freeze Templating.

Sakakibara N, Ito T, Terashima K.

Langmuir. 2019 Feb 26;35(8):3013-3019. doi: 10.1021/acs.langmuir.8b04117. Epub 2019 Feb 14. Erratum in: Langmuir. 2019 Mar 12;35(10):3869.

PMID:
30716274
10.

Clinical and Genetic Characteristics in Patients With Gitelman Syndrome.

Fujimura J, Nozu K, Yamamura T, Minamikawa S, Nakanishi K, Horinouchi T, Nagano C, Sakakibara N, Nakanishi K, Shima Y, Miyako K, Nozu Y, Morisada N, Nagase H, Ninchoji T, Kaito H, Iijima K.

Kidney Int Rep. 2018 Sep 28;4(1):119-125. doi: 10.1016/j.ekir.2018.09.015. eCollection 2019 Jan.

11.

Pair analysis and custom array CGH can detect a small copy number variation in COQ6 gene.

Nakanishi K, Okamoto T, Nozu K, Hara S, Sato Y, Hayashi A, Takahashi T, Nagano C, Sakakibara N, Horinouchi T, Fujimura J, Minamikawa S, Yamamura T, Rossanti R, Nagase H, Kaito H, Ariga T, Iijima K.

Clin Exp Nephrol. 2019 May;23(5):669-675. doi: 10.1007/s10157-018-1682-z. Epub 2018 Dec 24.

PMID:
30584653
12.

The utility of urinary CD80 as a diagnostic marker in patients with renal diseases.

Minamikawa S, Nozu K, Maeta S, Yamamura T, Nakanishi K, Fujimura J, Horinouchi T, Nagano C, Sakakibara N, Nagase H, Shima H, Noda K, Ninchoji T, Kaito H, Iijima K.

Sci Rep. 2018 Nov 23;8(1):17322. doi: 10.1038/s41598-018-35798-2.

13.

Clinical spectrum of male patients with OFD1 mutations.

Sakakibara N, Morisada N, Nozu K, Nagatani K, Ohta T, Shimizu J, Wada T, Shima Y, Yamamura T, Minamikawa S, Fujimura J, Horinouchi T, Nagano C, Shono A, Ye MJ, Nozu Y, Nakanishi K, Iijima K.

J Hum Genet. 2019 Jan;64(1):3-9. doi: 10.1038/s10038-018-0532-x. Epub 2018 Nov 6.

PMID:
30401917
14.

Novel amodiaquine derivatives potently inhibit Ebola virus infection.

Sakurai Y, Sakakibara N, Toyama M, Baba M, Davey RA.

Antiviral Res. 2018 Dec;160:175-182. doi: 10.1016/j.antiviral.2018.10.025. Epub 2018 Nov 3.

15.

Data on COA-Cl administration to the APP/PS2 double-transgenic mouse model of Alzheimer׳s disease: Improved hippocampus-dependent learning and unchanged spontaneous physical activity.

Kishimoto Y, Tsukamoto I, Nishigawa A, Nishimoto A, Kirino Y, Kato Y, Konishi R, Maruyama T, Sakakibara N.

Data Brief. 2018 Sep 19;20:1877-1883. doi: 10.1016/j.dib.2018.09.044. eCollection 2018 Oct.

16.

Determination of Inorganic Arsenic in Seaweed and Seafood by LC-ICP-MS: Method Validation.

Matsumoto-Tanibuchi E, Sugimoto T, Kawaguchi T, Sakakibara N, Yamashita M.

J AOAC Int. 2019 Mar 1;102(2):612-618. doi: 10.5740/jaoacint.18-0148. Epub 2018 Sep 11.

PMID:
30205865
17.

Negative pain management index scores do not necessarily indicate inadequate pain management: a cross-sectional study.

Sakakibara N, Higashi T, Yamashita I, Yoshimoto T, Matoba M.

BMC Palliat Care. 2018 Aug 24;17(1):102. doi: 10.1186/s12904-018-0355-8.

18.

TGFBI-associated corneal dystrophy and nephropathy: a novel syndrome?

Nagano C, Nozu K, Yamamura T, Minamikawa S, Fujimura J, Sakakibara N, Nakanishi K, Horinouchi T, Iwafuchi Y, Kusuhara S, Matsumiya W, Yoshikawa N, Iijima K.

CEN Case Rep. 2019 Feb;8(1):14-17. doi: 10.1007/s13730-018-0356-8. Epub 2018 Aug 7.

19.

Treatment selection for esophageal cancer: evaluation from a nationwide database.

Hamamoto Y, Sakakibara N, Nagashima F, Kitagawa Y, Higashi T.

Esophagus. 2018 Apr;15(2):109-114. doi: 10.1007/s10388-018-0605-0. Epub 2018 Feb 20.

PMID:
29892936
20.

Development of ultra-deep targeted RNA sequencing for analyzing X-chromosome inactivation in female Dent disease.

Minamikawa S, Nozu K, Nozu Y, Yamamura T, Taniguchi-Ikeda M, Nakanishi K, Fujimura J, Horinouchi T, Shima Y, Nakanishi K, Hattori M, Kanda K, Tanaka R, Morisada N, Nagano C, Sakakibara N, Nagase H, Morioka I, Kaito H, Iijima K.

J Hum Genet. 2018 May;63(5):589-595. doi: 10.1038/s10038-018-0415-1. Epub 2018 Feb 19.

PMID:
29459630
21.

Detection of copy number variations by pair analysis using next-generation sequencing data in inherited kidney diseases.

Nagano C, Nozu K, Morisada N, Yazawa M, Ichikawa D, Numasawa K, Kourakata H, Matsumura C, Tazoe S, Tanaka R, Yamamura T, Minamikawa S, Horinouchi T, Nakanishi K, Fujimura J, Sakakibara N, Nozu Y, Ye MJ, Kaito H, Iijima K.

Clin Exp Nephrol. 2018 Aug;22(4):881-888. doi: 10.1007/s10157-018-1534-x. Epub 2018 Jan 25.

PMID:
29372472
22.

Subclinical maternal depressive symptoms modulate right inferior frontal response to inferring affective mental states of adults but not of infants.

Shimada K, Kasaba R, Fujisawa TX, Sakakibara N, Takiguchi S, Tomoda A.

J Affect Disord. 2018 Mar 15;229:32-40. doi: 10.1016/j.jad.2017.12.031. Epub 2017 Dec 26.

23.

Congenital Cytomegalovirus Infection in Children with Autism Spectrum Disorder: Systematic Review and Meta-Analysis.

Maeyama K, Tomioka K, Nagase H, Yoshioka M, Takagi Y, Kato T, Mizobuchi M, Kitayama S, Takada S, Nagai M, Sakakibara N, Nishiyama M, Taniguchi-Ikeda M, Morioka I, Iijima K, Nishimura N.

J Autism Dev Disord. 2018 May;48(5):1483-1491. doi: 10.1007/s10803-017-3412-x.

PMID:
29185167
24.

Establishment of an antiviral assay system and identification of severe fever with thrombocytopenia syndrome virus inhibitors.

Baba M, Toyama M, Sakakibara N, Okamoto M, Arima N, Saijo M.

Antivir Chem Chemother. 2017 Dec;25(3):83-89. doi: 10.1177/2040206617740303. Epub 2017 Nov 3.

25.

Effect of COA-Cl on transforming growth factor-β1-induced epithelial-mesenchymal transition in RLE/Abca3 cells.

Kawami M, Deguchi J, Yumoto R, Sakakibara N, Tsukamoto I, Konishi R, Takano M.

Drug Metab Pharmacokinet. 2017 Aug;32(4):224-227. doi: 10.1016/j.dmpk.2017.05.001. Epub 2017 May 17.

PMID:
28736185
26.

Evaluation of a fixed-dose combination of benazepril and pimobendan in dogs with congestive heart failure: a randomized non-inferiority clinical trial.

King JN, Hirakawa A, Sonobe J, Otaki H, Sakakibara N, Seewald W, Forster S.

J Vet Sci. 2018 Jan 31;19(1):117-128. doi: 10.4142/jvs.2018.19.1.117.

27.

Synthesis and Evaluation of Novel Cyclopropane Nucleoside as Potential Tube Formation Agents.

Sakakibara N, Igarashi J, Takata M, Konishi R, Kato Y, Tsukamoto I.

Chem Pharm Bull (Tokyo). 2017;65(5):504-510. doi: 10.1248/cpb.c17-00056.

28.

High-mobility group box-1 release into fetal circulation from umbilical cord tissue and amniotic epithelium in fetal ischemia.

Nakamura T, Yoshioka T, Yamada S, Miyasho T, Sakakibara N, Hatanaka D.

Pediatr Int. 2016 Jul;58(7):631-4. doi: 10.1111/ped.12883. Epub 2016 Apr 21.

PMID:
27097754
29.

A key role of PGC-1α transcriptional coactivator in production of VEGF by a novel angiogenic agent COA-Cl in cultured human fibroblasts.

Igarashi J, Okamoto R, Yamashita T, Hashimoto T, Karita S, Nakai K, Kubota Y, Takata M, Yamaguchi F, Tokuda M, Sakakibara N, Tsukamoto I, Konishi R, Hirano K.

Physiol Rep. 2016 Mar;4(6). pii: e12742. doi: 10.14814/phy2.12742. Epub 2016 Mar 31.

30.

Design, synthesis, and anti-HIV-1 activity of 1-substituted 3-(3,5-dimethylbenzyl)triazine derivatives.

Sakakibara N, Balboni G, Congiu C, Onnis V, Demizu Y, Misawa T, Kurihara M, Kato Y, Maruyama T, Toyama M, Okamoto M, Baba M.

Antivir Chem Chemother. 2015 Apr;24(2):62-71. doi: 10.1177/2040206615612208. Epub 2015 Oct 28.

31.

Synthesis and Evaluation of Novel Carbocyclic Oxetanocin A (COA-Cl) Derivatives as Potential Tube Formation Agents.

Sakakibara N, Igarashi J, Takata M, Demizu Y, Misawa T, Kurihara M, Konishi R, Kato Y, Maruyama T, Tsukamoto I.

Chem Pharm Bull (Tokyo). 2015;63(9):701-9. doi: 10.1248/cpb.c15-00386.

32.

Design, synthesis, and anti-HIV-1 activity of 1-aromatic methyl-substituted 3-(3,5-dimethylbenzyl)uracil and N-3,5-dimethylbenzyl-substituted urea derivatives.

Sakakibara N, Baba M, Okamoto M, Toyama M, Demizu Y, Misawa T, Kurihara M, Irie K, Kato Y, Maruyama T.

Antivir Chem Chemother. 2015 Feb;24(1):3-18. doi: 10.1177/2040206614566584.

33.

Prenatal Nicotine Exposure Impairs the Proliferation of Neuronal Progenitors, Leading to Fewer Glutamatergic Neurons in the Medial Prefrontal Cortex.

Aoyama Y, Toriumi K, Mouri A, Hattori T, Ueda E, Shimato A, Sakakibara N, Soh Y, Mamiya T, Nagai T, Kim HC, Hiramatsu M, Nabeshima T, Yamada K.

Neuropsychopharmacology. 2016 Jan;41(2):578-89. doi: 10.1038/npp.2015.186. Epub 2015 Jun 24.

34.

Age-related and obstacle height-related differences in movements while stepping over obstacles.

Shin S, Demura S, Watanabe T, Yabumoto T, Shi B, Sakakibara N, Matsuoka T.

J Physiol Anthropol. 2015 Mar 24;34:15. doi: 10.1186/s40101-015-0052-8.

35.

One-Year Outcome of Endovenous Micropulsed Laser Ablation for Incompetent Great Saphenous Vein.

Sakakibara N, Kansaku R, Akashi H, Yamaoka H, Amano A.

J Vasc Surg Venous Lymphat Disord. 2015 Jan;3(1):126-7. doi: 10.1016/j.jvsv.2014.10.029. Epub 2014 Dec 15. No abstract available.

PMID:
26993715
36.

Involvement of S1P1 receptor pathway in angiogenic effects of a novel adenosine-like nucleic acid analog COA-Cl in cultured human vascular endothelial cells.

Igarashi J, Hashimoto T, Kubota Y, Shoji K, Maruyama T, Sakakibara N, Takuwa Y, Ujihara Y, Katanosaka Y, Mohri S, Naruse K, Yamashita T, Okamoto R, Hirano K, Kosaka H, Takata M, Konishi R, Tsukamoto I.

Pharmacol Res Perspect. 2014 Oct;2(5):e00068. doi: 10.1002/prp2.68. Epub 2014 Aug 6.

37.

[Chapter 2. Transitions in drug-discovery technology and drug-development in Japan (1980-2010)].

Sakakibara N, Yoshioka R, Matsumoto K.

Yakushigaku Zasshi. 2014;49(1):39-49. Japanese.

PMID:
25272636
38.

[Synthesis and evaluation of novel nucleic acid derivatives as bioactive substances].

Sakakibara N.

Yakugaku Zasshi. 2014;134(9):965-72. Review. Japanese.

39.

The onset of heat-induced testicular calcification in mice: involvement of the telomeric locus on chromosome 1.

Chihara M, Nakamura T, Sakakibara N, Otsuka S, Ichii O, Kon Y.

Am J Pathol. 2014 Sep;184(9):2480-92. doi: 10.1016/j.ajpath.2014.06.004. Epub 2014 Jul 18.

PMID:
25041854
40.

Histological difference between pulsed wave laser and continuous wave laser in endovenous laser ablation.

Kansaku R, Sakakibara N, Amano A, Endo H, Shimabukuro T, Sueishi M.

Phlebology. 2015 Jul;30(6):429-34. doi: 10.1177/0268355514538248. Epub 2014 May 30.

PMID:
24878667
41.

Intravascular lymphomatosis mimicking primary central nervous system lymphoma: a case report and literature review.

Oomura M, Sakakibara N, Suzuki S, Wakita A, Mori Y, Kamimoto K.

Case Rep Neurol. 2014 Mar 29;6(1):101-8. doi: 10.1159/000362121. eCollection 2014 Jan.

42.

Brd4 is displaced from HPV replication factories as they expand and amplify viral DNA.

Sakakibara N, Chen D, Jang MK, Kang DW, Luecke HF, Wu SY, Chiang CM, McBride AA.

PLoS Pathog. 2013;9(11):e1003777. doi: 10.1371/journal.ppat.1003777. Epub 2013 Nov 21.

43.

Validation of the Japanese version of the Fatigue Barriers Scale (JFBS).

Komatsu H, Watanabe C, Yagasaki K, Sakakibara N, Nakamura S.

Int J Palliat Nurs. 2013 Oct;19(10):503-9.

PMID:
24162281
44.

Synthesis and evaluation of novel 3-(3,5-dimethylbenzyl)uracil analogs as potential anti-HIV-1 agents.

Sakakibara N, Hamasaki T, Baba M, Demizu Y, Kurihara M, Irie K, Iwai M, Asada E, Kato Y, Maruyama T.

Bioorg Med Chem. 2013 Sep 15;21(18):5900-6. doi: 10.1016/j.bmc.2013.06.061. Epub 2013 Jul 3.

PMID:
23916148
45.

Papillomaviruses use recombination-dependent replication to vegetatively amplify their genomes in differentiated cells.

Sakakibara N, Chen D, McBride AA.

PLoS Pathog. 2013;9(7):e1003321. doi: 10.1371/journal.ppat.1003321. Epub 2013 Jul 4. No abstract available.

46.

Delayed administration of the nucleic acid analog 2Cl-C.OXT-A attenuates brain damage and enhances functional recovery after ischemic stroke.

Okabe N, Nakamura E, Himi N, Narita K, Tsukamoto I, Maruyama T, Sakakibara N, Nakamura T, Itano T, Miyamoto O.

Brain Res. 2013 Apr 19;1506:115-31. doi: 10.1016/j.brainres.2013.02.009. Epub 2013 Feb 14.

PMID:
23416149
47.

Aortic valve replacement to a patient with high titer of cold agglutinin.

Kansaku R, Kuwaki K, Amano A, Inaba H, Tambara K, Yamamoto T, Sakakibara N.

Ann Thorac Cardiovasc Surg. 2012;18(3):259-61.

48.

Comparison of oral robenacoxib and carprofen for the treatment of osteoarthritis in dogs: a randomized clinical trial.

Edamura K, King JN, Seewald W, Sakakibara N, Okumura M.

J Vet Med Sci. 2012 Sep;74(9):1121-31. Epub 2012 May 17.

49.

Pulmonary endarterectomy: recent changes in a single institution's experience of more than 2,700 patients.

Madani MM, Auger WR, Pretorius V, Sakakibara N, Kerr KM, Kim NH, Fedullo PF, Jamieson SW.

Ann Thorac Surg. 2012 Jul;94(1):97-103; discussion 103. doi: 10.1016/j.athoracsur.2012.04.004. Epub 2012 May 23.

PMID:
22626752
50.

Effect of long-term physical exercise of peripheral nerve: comparison of nerve conduction study and ultrasonography.

Watanabe T, Sakakibara N, Sugimori H, Yabumoto T, Takeyama T, Takemura M, Seishima M, Matsuoka T.

J Sports Med Phys Fitness. 2012 Apr;52(2):212-20.

PMID:
22525659

Supplemental Content

Loading ...
Support Center